[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Atrium Therapeutics Inc (RNA)

Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Atrium Therapeutics Inc 10578 Science Center Drive Suite 125 SAN DIEGO CA 92121 USA

https://atriumtherapeutics.com P: 619-876-0700

Sector:

Medical

Description:

Atrium Therapeutics Inc. is pioneering targeted delivery of ribonucleic acid therapeutics to the heart to transform the standard of care for people living with cardiomyopathies. The company's pipeline consists of precision cardiology candidates, ATR 1072 and ATR 1086. Atrium Therapeutics Inc. is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 233,326
Enterprise Value, $K 233,326
Shares Outstanding, K 17,106
Float, K 16,451
% Float 96.17%
Short Interest, K 3,514
Short Float 20.54%
Days to Cover 28.39
Short Volume Ratio 0.40
% of Insider Shareholders 3.83%

Financials:

Annual Sales, $ 18,760 K
Annual Net Income, $ -684,630 K
Last Quarter Sales, $ 3,000 K
Last Quarter Net Income, $ -20,190 K
EBIT, $ -60,210 K
EBITDA, $ -60,210 K

Growth:

1-Year Return -6.45%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.18 on 08/13/26
Next Earnings Date 11/12/26
Earnings Per Share ttm -2.15
EPS Growth vs. Prev Qtr -21.65%
EPS Growth vs. Prev Year 39.92%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

RNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -3,649.41%
Debt/Equity 0.00
Price/Sales 6.51
Price/Cash Flow N/A
Price/Book 1.11
Book Value/Share 12.54
Interest Coverage 0.00
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.